Literature DB >> 22348692

Using the experiences of people with familial hypercholesterolaemia to help reduce the risk of cardiovascular disease: a qualitative systematic review.

Lauretta A Muir1, Peter M George, Lisa Whitehead.   

Abstract

AIMS: This paper presents the results of a systematic review of qualitative studies identifying the experiences and perceptions of people living with familial hypercholesterolaemia.
BACKGROUND: Familial hypercholesterolaemia is a genetic condition that causes cardiovascular disease and early death. It can be easily diagnosed and treated. Diagnostic rates sit around 20% of the at-risk population in western countries. Screening the relatives of diagnosed people is the best way of identifying those at risk so that, if necessary, treatment can be offered. Presentation for screening can depend on diagnosed people informing relatives of their increased risk and advising them to volunteer for testing. We conducted this review to identify if this approach to screening contributes to low diagnostic and treatment rates. DATA SOURCES: Searches were made of 11 electronic databases and grey literature from 1990-February 2011. REVIEW
METHOD: A systematic review of studies that met the review aim was undertaken. Relevant data were extracted and a narrative synthesis conducted.
RESULTS: Poor health literacy, family and other social dynamics can both impede the ability and reduce the likelihood of diagnosed people approaching and adequately explaining the risk of familial hypercholesterolaemia to relatives. Relatives may misunderstand the significance of their messages or not see them as personally relevant.
CONCLUSION: To ensure contact takes place and relatives are able to make informed decisions around being tested, expert clinicians must evaluate the health literacy and social contexts of diagnosed people before assigning them responsibility for contacting family and actively provide support and follow up.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22348692     DOI: 10.1111/j.1365-2648.2012.05957.x

Source DB:  PubMed          Journal:  J Adv Nurs        ISSN: 0309-2402            Impact factor:   3.187


  7 in total

1.  Patients' perceptions and experiences of familial hypercholesterolemia, cascade genetic screening and treatment.

Authors:  Sarah J Hardcastle; Ellen Legge; Chris S Laundy; Sarah J Egan; Rosemary French; Gerald F Watts; Martin S Hagger
Journal:  Int J Behav Med       Date:  2015-02

2.  How do the experiences and beliefs of adults and children with heterozygous familial hypercholesterolaemia influence their adherence to treatment? A systematic review of qualitative evidence protocol.

Authors:  Fiona J Kinnear; Rachel Perry; Aidan Searle; Julian P Hamilton-Shield; Fiona E Lithander
Journal:  Syst Rev       Date:  2018-08-16

3.  Parents' views of genetic testing and treatment of familial hypercholesterolemia in children: a qualitative study.

Authors:  Karen Forrest Keenan; Robert M Finnie; William G Simpson; Lorna McKee; John Dean; Zosia Miedzybrodzka
Journal:  J Community Genet       Date:  2018-06-14

4.  The Impact of Proband Indication for Genetic Testing on the Uptake of Cascade Testing Among Relatives.

Authors:  Tara J Schmidlen; Sara L Bristow; Kathryn E Hatchell; Edward D Esplin; Robert L Nussbaum; Eden V Haverfield
Journal:  Front Genet       Date:  2022-06-16       Impact factor: 4.772

5.  Enablers and barriers to treatment adherence in heterozygous familial hypercholesterolaemia: a qualitative evidence synthesis.

Authors:  Fiona J Kinnear; Elaine Wainwright; Rachel Perry; Fiona E Lithander; Graham Bayly; Alyson Huntley; Jennifer Cox; Julian Ph Shield; Aidan Searle
Journal:  BMJ Open       Date:  2019-07-31       Impact factor: 2.692

6.  Nutrition and physical activity intervention for families with familial hypercholesterolaemia: protocol for a pilot randomised controlled feasibility study.

Authors:  Fiona J Kinnear; Julian P Hamilton-Shield; David J Stensel; Graham Bayly; Aidan Searle; Alice E Thackray; Fiona E Lithander
Journal:  Pilot Feasibility Stud       Date:  2020-04-02

7.  Thirty percent of children and young adults with familial hypercholesterolemia treated with statins have adherence issues.

Authors:  Gisle Langslet; Anja K Johansen; Martin P Bogsrud; Ingunn Narverud; Hilde Risstad; Kjetil Retterstøl; Kirsten B Holven
Journal:  Am J Prev Cardiol       Date:  2021-04-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.